This is an open letter from one of our friends, living with IBC. She also guest blogs for the IBC Network. Also on a side note, about 40% of women diagnosed with IBC are also triple negative. It is time to talk. Dear Ms. Lunden, I was thrilled to see your cover...
The IBC Network is honored to share this guest post from Oliver Bogler, Ph.D. He clearly outlines the gaps in research and how we can push to move the entire field of breast cancer advocacy a stage further. We hope you share this post and we look forward to your...
Kathleen K. Strosser has been living with Stage IV Inflammatory Breast Cancer since April, 2009. She is currently on a new chemotherapy agent approved just this past February. Kadcyla (Genentech) is a combination of herceptin and emtansine, and has far fewer side...
